Open AccessImpact of ivabradine in decompensated heart failure due to cancer therapy‐related cardiac dysfunction
Author(s) -
Nakano Yusuke,
Ando Hirohiko,
Suzuki Wataru,
Ohashi Hirofumi,
Suzuki Yasushi,
Takashima Hiroaki,
Amano Tetsuya
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4133
Subject(s) - ivabradine , medicine , heart failure , cardiology , acute decompensated heart failure , cardiac dysfunction , hemodynamics , stroke volume , cancer , heart rate , blood pressure , ejection fraction
Key Clinical Message In cases of decompensated heart failure related to cancer therapy‐related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorable hemodynamics. Assessment of the overlap between the E‐ and A‐waves facilitates understanding the effects of ivabradine in such cases.